APA (7th ed.) Citation

N, R., YA, R., EC, C., O, L., G, G., & G, T. (2022). Methodological and reporting issues for meta-analysis of immune checkpoint inhibitor-associated cardiotoxicity. Letter regarding the article 'Cardiotoxicity associated with immune checkpoint inhibitor therapy: A meta-analysis'. Reply. European journal of heart failure, 24(8), 1450. https://doi.org/10.1002/ejhf.2611

Chicago Style (17th ed.) Citation

N, Rubio-Infante, Ramírez-Flores YA, Castillo EC, Lozano O, García-Rivas G, and Torre-Amione G. "Methodological and Reporting Issues for Meta-analysis of Immune Checkpoint Inhibitor-associated Cardiotoxicity. Letter Regarding the Article 'Cardiotoxicity Associated with Immune Checkpoint Inhibitor Therapy: A Meta-analysis'. Reply." European Journal of Heart Failure 24, no. 8 (2022): 1450. https://doi.org/10.1002/ejhf.2611.

MLA (9th ed.) Citation

N, Rubio-Infante, et al. "Methodological and Reporting Issues for Meta-analysis of Immune Checkpoint Inhibitor-associated Cardiotoxicity. Letter Regarding the Article 'Cardiotoxicity Associated with Immune Checkpoint Inhibitor Therapy: A Meta-analysis'. Reply." European Journal of Heart Failure, vol. 24, no. 8, 2022, p. 1450, https://doi.org/10.1002/ejhf.2611.